Related Experiment Video
Updated: Jan 18, 2026

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
Published on: September 18, 2020
Effect of SMYD3 on biological behavior and H3K4 methylation in bladder cancer
Xiang Wu1,2, Qingjiang Xu1,2, Pingzhou Chen1,2
1Shengli Clinical Medical College of Fujian Medical University, Fuzhou 350001, People's Republic of China.
Purpose:
Our goal was to investigate the effect of SMYD3 on the biological behavior and histone 3 lysine-4 (H3K4) methylation of bladder cancer (BLAC).
Patients And Methods:
qRT-PCR identified that SMYD3 expression level in BLAC cell lines (T24, 5637, BUI-87 and J-82) and human normal uroepithelial cell line SV-HUC1. We also constructed green fluorescence protein lentiviral vector using the gene short hairpin RNA (shRNA) system. We used Western blot to analyze the SMYD3, H3K4me1, H3K4me2 and H3K4me3 expression levels in shRNA transfection lines. We also performed a colony-forming assay to determine colony-forming ability, cell counting kit-8 for cell proliferation detection, Transwell assay to determine cell migration and invasion and Annexin V-FITC/PI double staining to analyze cell apoptosis.
Results:
The SMYD3 expression level was significantly higher in BLAC cell lines (T24, 5637, BUI-87 and J-82) than in human normal uroepithelial cell line SV-HUC1, and exhibited the highest expression level in T24 cells, among the cell lines tested. qRT-PCR and Western blot analysis results showed that SMYD3 was successfully suppressed in shRNA transfection lines, and identified that SMYD3 suppression resulted inhibited H3K4me2 and H3K4me3 but not H3K4me1. SMYD3 knockdown cells accelerated cell apoptosis and exhibited low cell colony-forming ability, proliferation ability, inhibition of cell migration and invasion compared with normal cells.
Conclusion:
SMYD3 may be activated in BLAC cells to increase H3K4 activity to modulate cell proliferation, migration and invasion ability. The data will be a useful source for future therapy.
Insights
SMYD3 is elevated in bladder cancer cells, promoting proliferation and invasion. Suppressing SMYD3 inhibits cancer cell growth and induces apoptosis, offering potential therapeutic targets.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Bladder cancer (BLAC) is a significant health concern.
- SMYD3 is a gene implicated in various cancers.
- Histone methylation plays a crucial role in gene regulation and cancer development.
Purpose of the Study:
- To investigate the role of SMYD3 in bladder cancer.
- To analyze the effect of SMYD3 on histone 3 lysine-4 (H3K4) methylation.
- To determine SMYD3's impact on the biological behavior of bladder cancer cells.
Main Methods:
- Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) to assess SMYD3 expression.
- Short hairpin RNA (shRNA) system to suppress SMYD3 expression.
- Western blot to analyze protein levels of SMYD3 and H3K4 methylation marks (H3K4me1, H3K4me2, H3K4me3).
- Cell proliferation, colony formation, migration, invasion, and apoptosis assays were performed.
Main Results:
- SMYD3 expression was significantly higher in BLAC cell lines compared to normal uroepithelial cells.
- SMYD3 suppression using shRNA led to decreased H3K4me2 and H3K4me3 levels, but not H3K4me1.
- Knockdown of SMYD3 resulted in increased apoptosis, reduced colony formation, proliferation, migration, and invasion.
Conclusions:
- SMYD3 activation in bladder cancer cells enhances H3K4 methylation activity.
- SMYD3 modulates key cancer behaviors including proliferation, migration, and invasion.
- Targeting SMYD3 presents a potential therapeutic strategy for bladder cancer.
Related Concept Videos
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
Abnormal Proliferation

